In this digital age, information about us is being collected in various ways such as phones, wearables, search engines etc, it’s no surprise that we are sitting in a gold mine of information. When this huge chunk of data is analyzed by informatics tools, useful insights can be gleaned from it that could prove to be particularly useful, especially if its healthcare-related data.
IMS institute is one such organization that provides unique and transformational insights into healthcare dynamics derived from granular analysis of information.
Recently, the IMS Institute for Healthcare Informatics announced the launch of their new branch focused on supporting improved health outcomes across Asia. Based in Singapore, the team will forge relationships in the public and private sector and apply analytics-driven approaches, based on real-world evidence, for disease modeling and insights—providing regional markets with much-needed tools to make better and more cost-effective healthcare policy decisions.
In Asia, IMS Institute activities will focus on three areas:
- Mobilizing and advancing health services and systems research: The Institute will bring together leading policy advisors, educators, researchers and medical care providers to initiate research activities and apply evidence-based approaches to address key healthcare issues.
- Developing new insights on disease burden in Asia: The Institute will connect clinical, economic and patient-reported outcomes data to provide all stakeholders with deeper insights for improving the care of patients and their treatment journey experience.
- Advancing decision analytics in clinical practice and public policymaking: The Institute will support efforts by academia, clinicians, health administrators and policymakers to use real-world, data-driven decision analytics for more informed decision making and improved healthcare costs and outcomes.
“Like their peers around the globe, stakeholders across Asia are under increasing pressure to transform the focus of healthcare systems from volume to value,” said Murray Aitken, executive director, IMS Institute for Healthcare Informatics, which also has branches in China and India. “With growing recognition of the importance of real-world health data and analytics, our Asia branch will establish collaborative platforms that will bring stakeholders together to inform clinical and public policy decision making—addressing the ‘triple aim’ of population health, patient satisfaction and sustainable service costs.”
Collaborations with local partners:
The IMS Institute in Asia is collaborating with universities, research institutions, economic development agencies and governments—including Duke-NUS Medical School, National Cancer Centre Singapore, National University Hospital and InvitroCue Limited. Working with the public and private sectors and with the support of IMS Health, the IMS Institute Asia branch will conduct health services and systems research, decision analytical modeling, and studies to advance patient-centric care and value-based healthcare.
“Timely, high-quality and relevant information and insights are critical to informed strategies, productive dialogues and effective decision making in healthcare,” said Xavier Xuanhao Chan, PhD, director, IMS Institute for Healthcare Informatics in Asia. “We are excited to collaborate with other innovators and thought leaders in the region to address some of our most important challenges and opportunities.”